IGF-I and IGFBP-3 during continuous and interval exercise

International Journal of Sports Medicine

Volumn 29, Issue 3, 2008, Pages 182-187

  Copeland, Jennifer L ^a   Heggie, L ^a  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Cycling; Exercise intensity; Insulin like growth factor binding protein 3; Insulin like growth factor I; Interval exercise

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; BODY MASS; CYCLING; ENDURANCE; EXERCISE; HEMATOCRIT; HUMAN; MALE; NORMAL HUMAN; OXYGEN CONSUMPTION; STATISTICAL SIGNIFICANCE;

ADULT; EXERCISE; EXERCISE TEST; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PHYSICAL ENDURANCE; TIME FACTORS;

EID: 40649097298     PISSN: 01724622     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-965114     Document Type: Article

References (34)

1. Adams GR, Haddad F. The relationships among IGF-I, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol 1996; 81: 2509-2516
2. Bang P, Brandt J, Degerblad M, Enberg G, Kaijser L, Thoren M, Hall K. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency. Eur J Clin Invest 1990; 20: 285-292
3. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 1999; 107: 123-136
4. Berg U, Bang P. Exercise and circulating insulin-like growth factor I. Horm Res 2004; 62 (Suppl 1): 50-58
5. Bonnefoy M, Kostka T, Patricot MC, Berthouze SE, Mathian B, Lacour JR. Physical activity and dehydroepiandrosterone sulphate, insulin-like growth factor I and testosterone in healthy active elderly people. Age Ageing 1998; 27: 745-751
6. Brahm H, Piehl-Aulin K, Saltin B, Ljunghall S. Net fluxes over working thigh of hormones, growth factors and biomarkers of bone metabolism during short lasting dynamic exercise. Calcif Tissue Int 1997; 60: 175-180
7. Cappola AR, Bandeen-Roche K, Wand GS, Volpato S, Fried LP. Association of IGF-I levels with muscle strength and mobility in older women. J Clin Endocrinol Metab 2001; 86: 4139-4146
8. Cappon J, Brasel JA, Mohan S, Cooper DM. Effect of brief exercise on circulating insulin-like growth factor I. J Appl Physiol 1994; 76: 2490-2496
9. Chadan SG, Dill RP, Vanderhoek K, Parkhouse WS. Influence of physical activity on plasma insulin-like growth factor-1 and insulin-like growth factor binding proteins in healthy older women. Mech Ageing Dev 1999; 109: 21-34
10. Crewther B, Keogh J, Cronin J, Cook C. Possible stimuli for strength and power adaptation: acute hormonal responses. Sports Med 2006; 36: 215-238
11. Dall R, Lange KH, Kjaer M, Jorgensen JO, Christiansen JS, Orskov H, Flyvbjerg A. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes. J Clin Endocrinol Metab 2001; 86: 669-674
12. Donath MY, Jenni R, Brunner HP, Anrig M, Kohli S, Glatz Y, Froesch ER. Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humans. J Clin Endocrinol Metab 1996; 81: 4089-4094
13. Eliakim A, Oh Y, Cooper DM. Effect of single wrist exercise on fibroblast growth factor-2, insulin-like growth factor, and growth hormone. Am J Physiol 2000; 279: R548-R553
14. Friedenreich CM, Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 2002; 132: 3456S-3464S
15. Frystyk J, Nyholm B, Skjaerbaek C, Baxter RC, Schmitz O, Orskov H. The circulating IGF system and its relationship with 24-h glucose regulation and insulin sensitivity in healthy subjects. Clin Endocrinol (Oxf) 2003;58:777-784
16. Goldspink G, Harridge SD. Growth factors and muscle ageing. Exp Gerontol 2004; 39: 1433-1438
17. Hornum M, Cooper DM, Brasel JA, Bueno A, Sietsema KE. Exercise-induced changes in circulating growth factors with cyclic variation in plasma estradiol in women. J Appl Physiol 1997; 82: 1946-1951
18. Jackson A, Pollock M. Practical assessment of body composition. Phys Sportsmed 1985; 13: 76-90
19. Jenkins PJ, Bustin SA. Evidence for a link between IGF-I and cancer. Eur J Endocrinol 2004; 151 (Suppl 1): S17-S22
20. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34
21. Kostka T, Arsac LM, Patricot MC, Berthouze SE, Lacour JR, Bonnefoy M. Leg extensor power and dehydroepiandrosterone sulfate, insulin-like growth factor-I and testosterone in healthy active elderly people. Eur J Appl Physiol 2000; 82: 83-90
22. Kraemer WJ, Volek JS, Bush JA, Putukian M, Sebastianelli WJ. Hormonal responses to consecutive days of heavy-resistance exercise with or without nutritional supplementation. J Appl Physiol 1998; 85: 1544-1555
23. Kunitomi M, Wada J, Takahashi K, Tsuchiyama Y, Mimura Y, Hida K, Miyatake N, Fujii M, Kira S, Shikata K, Maknio H. Relationship between reduced serum IGF-I levels and accumulation of visceral fat in Japanese men. Int J Obes Relat Metab Disord 2002; 26: 361-369
24. Lundvall J, Lindgren P. F-cell shift and protein loss strongly affect validity of PV reductions indicated by Hb/Hct and plasma proteins. J Appl Physiol 1998; 84: 822-829
25. Mohan S, Baylink DJ, Pettis JL. Insulin-like growth factor (IGF)-binding proteins in serum - do they have additional roles besides modulating the endocrine IGF actions? J Clin Endocrinol Metab 1996; 81: 3817-3820
26. Nguyen UN, Mougin F, Simon-Rigaud ML, Rouillon JD, Marguet P, Regnard J. Influence of exercise duration on serum insulin-like growth factor and its binding proteins in athletes. Eur J Appl Physiol 1998; 78: 533-537
27. Nindl BC, Kraemer WJ, Marx JO, Arciero PJ, Dohi K, Kellogg MD, Loomis GA. Overnight responses of the circulating IGF-I system after acute, heavy-resistance exercise. J Appl Physiol 2001; 90: 1319-1326
28. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003; 28: 916-931
29. Rosen CJ. Insulin-like growth factor I and bone mineral density: experience from animal models and human observational studies. Best Pract Res Clin Endocrinol Metab 2004; 18: 423-435
30. Rosendal L, Langberg H, Flyvbjerg A, Frystyk J, Orskov H, Kjaer M. Physical capacity influences the response of insulin-like growth factor and its binding proteins to training. J Appl Physiol 2002; 93: 1669-1675
31. Schwarz AJ, Brasel JA, Hintz RL, Mohan S, Cooper DM. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 1996; 81: 3492-3497
32. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994; 15: 80-101
33. Tissandier O, Peres G, Fiet J, Piette F. Testosterone, dehydroepiandrosterone, insulin-like growth factor 1, and insulin in sedentary and physically trained aged men. Eur J Appl Physiol 2001; 85: 177-184
34. Van Beaumont W. Evaluation of hemoconcentration from hematocrit measurements. J Appl Physiol 1972; 32: 712-713